Carmichael Hill & Associates, Inc. Axsome Therapeutics, Inc. Transaction History

Carmichael Hill & Associates, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	BUY	$23.7 - $41.39 $2,370 - $4,139	100 Added 100.0%	200 $8,000
Q3 2021 Nov 12, 2021	SELL	$19.91 - $68.26 $3,982 - $13,652	-200 Reduced 66.67%	100 $3,000
Q2 2021 Aug 03, 2021	BUY	$50.63 - $73.5 $2,531 - $3,675	50 Added 20.0%	300 $20,000
Q2 2020 Aug 05, 2020	SELL	$49.87 - $98.69 $12,467 - $24,672	-250 Reduced 50.0%	250 $21,000
Q1 2020 May 05, 2020	SELL	$41.2 - $101.31 $12,360 - $30,393	-300 Reduced 37.5%	500 $29,000
Q4 2019 Jan 30, 2020	BUY	$16.71 - $106.24 $13,368 - $84,992	800 New	800 $83,000

332

38.3M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $4.7B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Carmichael Hill & Associates, Inc., based on Form 13F filings with the SEC.

Stay updated on Carmichael Hill & Associates, Inc. with notifications on news.